Characterisation of the Novel HLA‐B*39:247 Allele by Next Generation Sequencing
HLA · 2026-11 · 108 (5)
DOI: 10.1111/tan.71096 ↗Kurz gefasst
Leserbrief in der Zeitschrift HLA, online erschienen am 17.11.2026. Verfasst von Julien Lion und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department Histocompatibility, Amiens University Medical Centre, Amiens, France. Hauptthemen laut MEDLINE: Alleles, Exons, High-Throughput Nucleotide Sequencing, Polymorphism, Single Nucleotide. Die Arbeit nennt 3 Literaturangaben.
Abstract (Originalsprache)
HLA‐B*39:247 differs from the HLA‐B*39:06:02:01 allele by one nucleotide at position 684 in Exon 2.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department Histocompatibility, Amiens University Medical Centre, Amiens, France.
ORCID-Profile: Nicolas Guillaume
Zitieren
APA
Lion, J., Dollerschell, M., De Rupilly, C. L. B., & Guillaume, N. (2026). Characterisation of the Novel HLA‐B*39:247 Allele by Next Generation Sequencing. HLA, 108(5). https://doi.org/10.1111/tan.71096
Vancouver
Lion J, Dollerschell M, De Rupilly CLB, Guillaume N. Characterisation of the Novel HLA‐B*39:247 Allele by Next Generation Sequencing. HLA. 2026;108(5). doi:10.1111/tan.71096
BibTeX
@article{Lion2026,
author = {Lion, Julien and Dollerschell, Myriam and De Rupilly, Claire Le Boucq and Guillaume, Nicolas},
title = {Characterisation of the Novel HLA‐B*39:247 Allele by Next Generation Sequencing},
journal = {HLA},
year = {2026},
volume = {108},
number = {5},
doi = {10.1111/tan.71096}
}
EUVIMED